Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Samama

Showing results (541-550 of 677) with videos related to

Pageof 68
Sort By:
Chest|July 24, 2008
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Jack Hirsh, Kenneth A Bauer, Maria B Donati, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1990
[Peri- and postoperative use of low molecular weight heparin in peripheral vascular surgery]C M Samama, S Mouren, M P Bridel, et al.
Thrombosis and Haemostasis|December 1, 1996
The antithrombotic potential of dalteparin in man assessed indirectly by Wessler's techniqueJ Millet, J Theveniaux, G Tachon, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1987
Specific determination and identification of cross-linked fibrin degradation products in patients under thrombolytic therapy for myocardial infarctionJ Soria, C Soria, M Mirshahi, et al.
Annales Francaises D'Anesthesie Et De Reanimation|September 3, 2013
[Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013]G Pernod, P Albaladejo, A Godier, et al.
Archives of Cardiovascular Diseases|July 2, 2013
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013Gilles Pernod, Pierre Albaladejo, Anne Godier, et al.
Platelets|November 4, 2010
Original Article: Streptokinase Modifies in Vitro Platelet Aggregation by Two Mechanisms: Reduced Aggregation due to Fibrinogenolysis and Enhanced Aggregation via an Immunological ReactionM Abdelouahed, I Elalamy, J Lebrazi, et al.
Thrombosis and Haemostasis|July 3, 2009
Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparinGrigoris T Gerotziafas, Charlotte Dupont, Alex C Spyropoulos, et al.
Blood|September 28, 2002
Protein S Gla-domain mutations causing impaired Ca(2+)-induced phospholipid binding and severe functional protein S deficiencySuely M Rezende, David A Lane, Blandine Mille-Baker, et al.
Thrombosis Research|March 1, 1993
Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitorL Bara, M F Bloch, D Zitoun, et al.
Pageof 68

Showing results (541-550 of 677) with videos related to

Sort By:
Pageof 68
Chest|July 24, 2008
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Jack Hirsh, Kenneth A Bauer, Maria B Donati, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1990
[Peri- and postoperative use of low molecular weight heparin in peripheral vascular surgery]C M Samama, S Mouren, M P Bridel, et al.
Thrombosis and Haemostasis|December 1, 1996
The antithrombotic potential of dalteparin in man assessed indirectly by Wessler's techniqueJ Millet, J Theveniaux, G Tachon, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1987
Specific determination and identification of cross-linked fibrin degradation products in patients under thrombolytic therapy for myocardial infarctionJ Soria, C Soria, M Mirshahi, et al.
Annales Francaises D'Anesthesie Et De Reanimation|September 3, 2013
[Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013]G Pernod, P Albaladejo, A Godier, et al.
Archives of Cardiovascular Diseases|July 2, 2013
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013Gilles Pernod, Pierre Albaladejo, Anne Godier, et al.
Platelets|November 4, 2010
Original Article: Streptokinase Modifies in Vitro Platelet Aggregation by Two Mechanisms: Reduced Aggregation due to Fibrinogenolysis and Enhanced Aggregation via an Immunological ReactionM Abdelouahed, I Elalamy, J Lebrazi, et al.
Thrombosis and Haemostasis|July 3, 2009
Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparinGrigoris T Gerotziafas, Charlotte Dupont, Alex C Spyropoulos, et al.
Blood|September 28, 2002
Protein S Gla-domain mutations causing impaired Ca(2+)-induced phospholipid binding and severe functional protein S deficiencySuely M Rezende, David A Lane, Blandine Mille-Baker, et al.
Thrombosis Research|March 1, 1993
Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitorL Bara, M F Bloch, D Zitoun, et al.
Pageof 68